Abbott Laboratories
⚠️ High Risk
FEI: 1415939 • Abbott Park, IL • UNITED STATES
FEI Number
1415939
Location
Abbott Park, IL
Country
UNITED STATESAddress
100 Abbott Park Rd Bldg Ap8b, , Abbott Park, IL, United States
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
AGR RX
The article appears to be a prescription drug manufactured in the U.S. and offered for import by other than the manufacturer and reimportation does not appear to have been authorized by the Secretary for use in a medical emergency.
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
DRUG GMPS
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).
REGISTERED
It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(o) in that it is being imported or offered for import into the United States, and the importer, owner, or consignee of such article did not, at the time of offering the article for import, submit to the Secretary a statement that identifies the registration under section 510(i) of the Act of each establishment that with respect to such article is required under such section to register with the Secretary.
NO 510(K)
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.
INSANITARY
The article is subject to refusal of admission pursuant to section 801(a)(3) in that the article appears to have been prepared, packed, or held under insanitary conditions whereby it may have been contaminated with filth, or whereby it may have been rendered injurious to health.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 12/19/2025 | 64MDY01CLOMIPHENE CITRATE (GONAD-STIMULATING PRINCIPLE) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 9/12/2025 | 66TCE03FEBUXOSTAT (XANTHINE OXIDASE INHIBITOR) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/4/2025 | 58SCY14ADALIMUMAB | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/4/2025 | 58SDY14ADALIMUMAB | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/7/2025 | 58SCK14ADALIMUMAB | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 1/7/2025 | 58SCY14ADALIMUMAB | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 1/6/2025 | 58SCY14ADALIMUMAB | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/8/2022 | 66JCY01LEVOTHYROXINE SODIUM (THYROID HORMONE) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/11/2022 | 83QLWCOVID-19 TEST HOME COLLECTION KIT DEVICES | 508NO 510(K) | Division of West Coast Imports (DWCI) |
| 12/27/2021 | 61FCC56CLARITHROMYCIN (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/28/2021 | 62OCY10TERAZOSIN HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/5/2019 | 66SCA03BETAHISTINE HCL (VASODILATOR) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 10/22/2019 | 66VDY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/4/2019 | 66JCB01LEVOTHYROXINE SODIUM (THYROID HORMONE) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/28/2018 | 62IDY86LEUPROLIDE ACETATE (ANTI-NEOPLASTIC) | Division of Northern Border Imports (DNBI) | |
| 4/4/2013 | 62VIY37RITONAVIR (ANTI-VIRAL) | Florida District Office (FLA-DO) | |
| 4/6/2012 | 56IDA10ERYTHROMYCIN (MACROLIDES) | Division of Southeast Imports (DSEI) | |
| 8/26/2008 | 56YIP99ANTIBIOTIC N.E.C. | 75UNAPPROVED | Philadelphia District Office (PHI-DO) |
| 10/2/2007 | 61LDP26ARDEPARIN SODIUM (ANTI-COAGULANT) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 6/28/2005 | 62VCA13RIMANTADINE HCL (ANTI-VIRAL) | 179AGR RX | New Orleans District Office (NOL-DO) |
| 11/2/2004 | 60QDS67LIDOCAINE (ANESTHETIC) | 186INSANITARY | Southwest Import District Office (SWI-DO) |
| 3/12/2004 | 61LCP20ANTI-COAGULANT CITRATE DEXTROSE SOLUTION | 179AGR RX | Chicago District Office (CHI-DO) |
| 3/12/2004 | 60CCP04EPINEPHRINE (ADRENERGIC) | 179AGR RX | Chicago District Office (CHI-DO) |
| 3/12/2004 | 61LCP20ANTI-COAGULANT CITRATE DEXTROSE SOLUTION | 179AGR RX | Chicago District Office (CHI-DO) |
| 3/12/2004 | 60CCP04EPINEPHRINE (ADRENERGIC) | 179AGR RX | Chicago District Office (CHI-DO) |
| 8/27/2003 | 61LCP20ANTI-COAGULANT CITRATE DEXTROSE SOLUTION | 179AGR RX | Chicago District Office (CHI-DO) |
| 8/27/2003 | 60CCP04EPINEPHRINE (ADRENERGIC) | 179AGR RX | Chicago District Office (CHI-DO) |
| 8/27/2003 | 61LCP20ANTI-COAGULANT CITRATE DEXTROSE SOLUTION | 179AGR RX | Chicago District Office (CHI-DO) |
| 8/27/2003 | 60CCP04EPINEPHRINE (ADRENERGIC) | 179AGR RX | Chicago District Office (CHI-DO) |
| 6/26/2003 | 61LCP20ANTI-COAGULANT CITRATE DEXTROSE SOLUTION | 179AGR RX | Chicago District Office (CHI-DO) |
| 6/26/2003 | 60CCP04EPINEPHRINE (ADRENERGIC) | 179AGR RX | Chicago District Office (CHI-DO) |
| 5/1/2003 | 61LCP20ANTI-COAGULANT CITRATE DEXTROSE SOLUTION | 179AGR RX | Chicago District Office (CHI-DO) |
| 5/1/2003 | 60CCP04EPINEPHRINE (ADRENERGIC) | 179AGR RX | Chicago District Office (CHI-DO) |
| 5/1/2003 | 61LCP20ANTI-COAGULANT CITRATE DEXTROSE SOLUTION | 179AGR RX | Chicago District Office (CHI-DO) |
| 5/1/2003 | 60CCP04EPINEPHRINE (ADRENERGIC) | 179AGR RX | Chicago District Office (CHI-DO) |
| 3/31/2003 | 61LCP20ANTI-COAGULANT CITRATE DEXTROSE SOLUTION | 179AGR RX | Chicago District Office (CHI-DO) |
| 3/31/2003 | 60CCP04EPINEPHRINE (ADRENERGIC) | 179AGR RX | Chicago District Office (CHI-DO) |
| 3/31/2003 | 61LCP20ANTI-COAGULANT CITRATE DEXTROSE SOLUTION | 118NOT LISTED | Chicago District Office (CHI-DO) |
| 3/31/2003 | 60CCP04EPINEPHRINE (ADRENERGIC) | 118NOT LISTED | Chicago District Office (CHI-DO) |
| 12/3/2002 | 61LCP20ANTI-COAGULANT CITRATE DEXTROSE SOLUTION | 179AGR RX | Chicago District Office (CHI-DO) |
| 12/3/2002 | 60CCP04EPINEPHRINE (ADRENERGIC) | 179AGR RX | Chicago District Office (CHI-DO) |
| 7/23/2002 | 56IXS10ERYTHROMYCIN (MACROLIDES) | 118NOT LISTED | New York District Office (NYK-DO) |
| 6/26/2002 | 88JCCPH BUFFER | Chicago District Office (CHI-DO) |
Frequently Asked Questions
What is Abbott Laboratories's FDA import refusal history?
Abbott Laboratories (FEI: 1415939) has 43 FDA import refusal record(s) in our database, spanning from 6/26/2002 to 12/19/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Abbott Laboratories's FEI number is 1415939.
What types of violations has Abbott Laboratories received?
Abbott Laboratories has been cited for 8 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Abbott Laboratories come from?
All FDA import refusal data for Abbott Laboratories is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.